Cytokine profiles of experimental autoimmune myasthenia gravis after treatment by the synthetic immunomodulator linomide.
Zhang
G X
GX
Division of Neurology, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden.
Yu
L Y
LY
Shi
F D
FD
Xiao
B G
BG
Björk
J
J
Hedlund
G
G
Link
H
H
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D016207:Cytokines / Q000096:biosynthesis*; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D006912:Hydroxyquinolines / Q000627:therapeutic use*; D009157:Myasthenia Gravis / Q000276:immunology* / Q000503:physiopathology / Q000628:therapy; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D011917:Rats, Inbred Lew; D018417:Th1 Cells / Q000187:drug effects / Q000276:immunology*; D018418:Th2 Cells / Q000187:drug effects / Q000276:immunology*; D013997:Time Factors; D014158:Transcription, Genetic / Q000187:drug effects
D000276:Adjuvants, Immunologic; D016207:Cytokines; D006912:Hydroxyquinolines; D012333:RNA, Messenger; C045282:roquinimex